Developing a paclitaxel-coated drug-eluting balloon (DEB) for use in treating peripheral vascular disease
- Year invested 2011
- Investment Stage Early
- Sectors
- Investment Status Historic
- Website cvingenuity.com
- Company Status Acquired (by Covidien)
Developing a paclitaxel-coated drug-eluting balloon (DEB) for use in treating peripheral vascular disease